Your browser doesn't support javascript.
loading
Ascending Single-Dose, Double-Blind, Placebo-Controlled Safety Study of Noribogaine in Opioid-Dependent Patients.
Glue, Paul; Cape, Gavin; Tunnicliff, Donna; Lockhart, Michelle; Lam, Fred; Hung, Noelyn; Hung, C Tak; Harland, Sarah; Devane, Jane; Crockett, R S; Howes, John; Darpo, Borje; Zhou, Meijian; Weis, Holger; Friedhoff, Lawrence.
Afiliação
  • Glue P; University of Otago, Dunedin, New Zealand.
  • Cape G; Southern District Health Board, Dunedin, New Zealand.
  • Tunnicliff D; Southern District Health Board, Dunedin, New Zealand.
  • Lockhart M; University of Auckland, Auckland, New Zealand.
  • Lam F; Zenith Technology Ltd, Dunedin, New Zealand.
  • Hung N; University of Otago, Dunedin, New Zealand.
  • Hung CT; Zenith Technology Ltd, Dunedin, New Zealand.
  • Harland S; University of Otago, Dunedin, New Zealand.
  • Devane J; DemeRx, Inc, Fort Lauderdale, FL, USA.
  • Crockett RS; Design and Analysis of Trials Associates, Inc, Grand Bay, AL, USA.
  • Howes J; DemeRx, Inc, Fort Lauderdale, FL, USA.
  • Darpo B; iCardiac Technologies, Rochester, NY, USA.
  • Zhou M; Karolinska Institutet, Division of Cardiovascular Medicine, Department of Clinical Sciences, Danderyd's Hospital, Stockholm, Sweden.
  • Weis H; iCardiac Technologies, Rochester, NY, USA.
  • Friedhoff L; DemeRx, Inc, Fort Lauderdale, FL, USA.
Clin Pharmacol Drug Dev ; 5(6): 460-468, 2016 Nov.
Article em En | MEDLINE | ID: mdl-27870477

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ibogaína Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ibogaína Idioma: En Ano de publicação: 2016 Tipo de documento: Article